Patients with hematologic cancers often require a combination of inpatient and outpatient care. The oncology nurse navigator is an ideal care provider to help patients manage their care and transitions between care settings, according to a presentation at the 2018 ONA Navigation Summit.
There have been many recent changes in lung cancer, including updated early detection possibilities and changes in diagnostic procedures, reporting, and treatment options. These are reviewed in a presentation at the 2018 ONA Navigation Summit.
A review of immunotherapy — what they are, how they work, and what to watch for — was presented at the 2018 ONA Navigation Summit.
Suggestions for communication points that improve the experience of patients with cancer through nurse navigation were presented at the 2018 ONA Navigation Summit.
The unique challenges that face both oncology nurse navigators specializing in gastrointestinal cancer and patients with these diseases are reviewed in a presentation at the 2018 ONA Navigation Summit.
Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse NavigatorJune 15, 2018
The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.
Creating a multidisciplinary breast clinic can ensure that patients with breast cancer receive care that is timely, effective, and efficient, according to a presentation at the 2018 ONA Navigation Summit.
The technology will facilitate data entry for patient navigation activities, evaluation of one or more patient navigators (PNs), and generate reports.
Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient's ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.
A discussion and review of how to develop a successful nurse or patient navigation program is presented at the 2018 ONA Navigation Summit.
Now well established within the cancer care continuum, this presentation at the 2018 ONA Navigation Summit discussed the forces expanding the use of oncology navigation as well as the evolving role of the oncology nurse navigator.
Oncology nurse navigators tend to forget the most important person in the cancer care continuum: themselves. In this keynote presentation at the 2018 ONA Navigation Summit, Deborah Boyle, RN, MSN, AOCNS®, FAAN, talks about the importance of self care.
A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.
An assessment of more than 71,000 patients with leukemia demonstrated the difference in outcomes for patients admitted to hospital on the weekend vs weekday. Findings were presented at the 2018 ASCO Annual Meeting.
An intervention utilizing lay health workers supervised by NPs lowered health care costs and improved patient satisfaction.
Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.
Children's Oncology Group study reported on the effect of dexrazoxane on cardiotoxicity of anthracycline-containing regimens in pediatric patients with AML at the 2018 ASCO Annual Meeting.
In a multicenter phase 2 study, the Walk With Ease program was evaluated for its effectiveness in reducing radiotherapy-associated fatigue vs usual care in older patients with breast cancer. Results were presented at 2018 ASCO Annual Meeting.
Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.
Study presented at 2018 ASCO Annual Meeting determined the feasibility of using a mindfulness intervention to improve quality of life and confidence in advance care planning discussions among patient-family caregiver dyads.
Consultations for palliative care for hospitalized highly symptomatic patients with cancer is low regardless of curability or whether patient has hematologic or solid cancer, a study presented at 2018 ASCO has shown.
Long-term analysis determined the effect of postadjuvant dose-dense chemotherapy on DLCO among women with breast cancer.
Survey results presented at the 2018 ASCO Annual Meeting demonstrated the effects of financial toxicity on patients with early stage breast cancer.
In a case study, olaparib was found to induce folate deficiency in most patients with relapsed ovarian cancer. Researchers discuss the significance of this adverse effect and how it was managed.
In fielding reports of CNS-related adverse effects from patients in the ambulatory infusion room, nurses were able to prompt a pharmacy practice review. The outcomes of the resulting switch in premedication for HSR was presented at the 2018 ONS Annual Congress.
A clinic staffed with clinical research nurses provided needed care for patients in clinical trials who experienced adverse effects, and also ensured consistent documentation of treatment-related AEs, according to a presentation at the 2018 ONS Annual Congress.
Researchers reported on their study that investigated the feasibility of operating a same-day clinic for urgent care for patients currently receiving cancer treatment. These results were presented at the 2018 ONS Annual Congress.
The importance of oncology clinical research nurses in the clinical trial process was explored in a study presented at the 2018 ONS Annual Congress.
Researchers sought to determine the effectiveness of a multimodal continuity of care program for women receiving radiation therapy for gynecologic or lower GI cancers. Their findings were presented at the 2018 ONS Annual Congress.
A study presented at the 2018 ONS Annual Congress explored the feasibility of an advanced practice nurse-led lung cancer screening program at ambulatory outpatient clinics.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- The Caregivers' Cancer Journey
- Staff Education Leads to Increase in Oncology Rehabilitation Referrals
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Gender Bias in Medicine Has Far-Reaching Consequences
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Patient Interest in Melanoma Genetic Risk Testing is Fairly High
- Genetic Link Between Depression and Breast Cancer Remains Unclear
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|